137 related articles for article (PubMed ID: 21781496)
1. [Effects of HO-1 gene expression on proliferation of imatinib resistant CML cells].
Wang JS; Chai BS; Fang Q; He YY; Chen C; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):388-91. PubMed ID: 21781496
[TBL] [Abstract][Full Text] [Related]
2. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro].
Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538
[TBL] [Abstract][Full Text] [Related]
3. [The effect of retrovirus-mediated HO-1 gene on chronic myeloid leukemia resistance cell K562/A02 apoptosis induced by nilotinib].
Chen C; Wang JS; Qin D; Yang Y; Yu YY; Fang Q
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):383-7. PubMed ID: 22781797
[TBL] [Abstract][Full Text] [Related]
4. Induction of heme oxygenase-1 by Na+-H+ exchanger 1 protein plays a crucial role in imatinib-resistant chronic myeloid leukemia cells.
Ma D; Fang Q; Wang P; Gao R; Wu W; Lu T; Cao L; Hu X; Wang J
J Biol Chem; 2015 May; 290(20):12558-71. PubMed ID: 25802333
[TBL] [Abstract][Full Text] [Related]
5. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
[TBL] [Abstract][Full Text] [Related]
6. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.
Wang W; Zhang J; Li Y; Yang X; He Y; Li T; Ren F; Zhang J; Lin R
Cancer Lett; 2015 Jan; 356(2 Pt B):791-9. PubMed ID: 25449787
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway.
Li X; Miao H; Zhang Y; Li W; Li Z; Zhou Y; Zhao L; Guo Q
Arch Toxicol; 2015 Jan; 89(1):121-36. PubMed ID: 24671465
[TBL] [Abstract][Full Text] [Related]
8. Imatinib inhibits the expression of SCO2 and FRATAXIN genes that encode mitochondrial proteins in human Bcr-Abl⁺ leukemia cells.
Papadopoulou LC; Kyriazou AV; Bonovolias ID; Tsiftsoglou AS
Blood Cells Mol Dis; 2014; 53(1-2):84-90. PubMed ID: 24726617
[TBL] [Abstract][Full Text] [Related]
9. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
Wei YL; Liang Y; Xu L; Zhao XY
Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
[TBL] [Abstract][Full Text] [Related]
10. [Effect of neferine on the chemotherapic sensitivity of STI 571 to K562/A02 cells].
Xiao XB; Xie ZX; Chen J; Qin Q; Zhu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):558-61. PubMed ID: 16320588
[TBL] [Abstract][Full Text] [Related]
11. Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylate.
Jørgensen HG; Allan EK; Mountford JC; Richmond L; Harrison S; Elliott MA; Holyoake TL
Exp Hematol; 2005 Oct; 33(10):1140-6. PubMed ID: 16219536
[TBL] [Abstract][Full Text] [Related]
12. [Suppression of NAMPT expression enhances the sensitivity of K562 cells to imatinib and its relative mechanism].
Lin PP; Bai XJ; Yue ZX; Yan SF; Li ZW; Gao C; Mei YY; Wang KL; Li WJ; Ding W; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):235-41. PubMed ID: 22541073
[TBL] [Abstract][Full Text] [Related]
13. Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells.
Tibullo D; Barbagallo I; Giallongo C; La Cava P; Parrinello N; Vanella L; Stagno F; Palumbo GA; Li Volti G; Di Raimondo F
Curr Pharm Des; 2013; 19(15):2765-70. PubMed ID: 23092325
[TBL] [Abstract][Full Text] [Related]
14. [Apoptosis-inducing effect of tetrandrine and imatinib on K562/G01 cells and its related mechanism].
Shi DX; Ma LM; Lu YJ; Bai B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):723-8. PubMed ID: 24989284
[TBL] [Abstract][Full Text] [Related]
15. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells.
Gottschalk S; Anderson N; Hainz C; Eckhardt SG; Serkova NJ
Clin Cancer Res; 2004 Oct; 10(19):6661-8. PubMed ID: 15475456
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase-1 reduces the sensitivity to imatinib through nonselective activation of histone deacetylases in chronic myeloid leukemia.
Wei D; Lu T; Ma D; Yu K; Li X; Chen B; Xiong J; Zhang T; Wang J
J Cell Physiol; 2019 Apr; 234(4):5252-5263. PubMed ID: 30256411
[TBL] [Abstract][Full Text] [Related]
18. Heme oxygenase-1 contributes to imatinib resistance by promoting autophagy in chronic myeloid leukemia through disrupting the mTOR signaling pathway.
Cao L; Wang J; Ma D; Wang P; Zhang Y; Fang Q
Biomed Pharmacother; 2016 Mar; 78():30-38. PubMed ID: 26898422
[TBL] [Abstract][Full Text] [Related]
19. [Reversal of multidrug-resistance in human leukemia cell line K562/A02 by tyrosine kinase inhibitors].
Shan XY; Chen BA; Xia GH; Xu WL; Ding JH; Gao C; Sun YY; Wang J; Cheng J; Zhao G; Bao W; Song HH; Gao F; Wang F; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):90-5. PubMed ID: 20137125
[TBL] [Abstract][Full Text] [Related]
20. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ
Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
